<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Institute of Public Health</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2BBC7486-8B05-4571-BF25-D4D59D4E4946"><gtr:id>2BBC7486-8B05-4571-BF25-D4D59D4E4946</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Farmer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/46F9DB7E-4379-4950-94C7-F8B44FF3CA8F"><gtr:id>46F9DB7E-4379-4950-94C7-F8B44FF3CA8F</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Sutton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F5CAA77C-76C2-44C1-B847-D7E4DF60C55D"><gtr:id>F5CAA77C-76C2-44C1-B847-D7E4DF60C55D</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Griffin</gtr:surname><gtr:orcidId>0000-0002-2157-4797</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E4D6E47B-54DC-4862-AE76-8748983DA5D4"><gtr:id>E4D6E47B-54DC-4862-AE76-8748983DA5D4</gtr:id><gtr:firstName>Wendy</gtr:firstName><gtr:surname>Hardeman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BA3CAF6A-D534-4763-8317-FCC2FC5C4B6A"><gtr:id>BA3CAF6A-D534-4763-8317-FCC2FC5C4B6A</gtr:id><gtr:firstName>Toby</gtr:firstName><gtr:surname>Prevost</gtr:surname><gtr:orcidId>0000-0003-1723-0796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/976F6B3B-EFBC-4874-A746-3776C9997384"><gtr:id>976F6B3B-EFBC-4874-A746-3776C9997384</gtr:id><gtr:firstName>Ann</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Kinmonth</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500267"><gtr:id>E6F85F0C-CB08-4D9B-B72C-B2A8F0F5CC35</gtr:id><gtr:title>Supported Adherence to Medication</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500267</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>195240</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lay particiaption Group Oxfordshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>393DB4AF-7C23-4476-BA40-A2B8806E8A8A</gtr:id><gtr:impact>Presentation of research

Support for further work arising from this programme and input to research design</gtr:impact><gtr:outcomeId>D0DF7E449FD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>stroke patients / pharmacy (AdeS)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B7EB92F9-F185-4397-A425-E6139A5AA2D4</gtr:id><gtr:impact>to inform a behaviour change intervention for stroke patients</gtr:impact><gtr:outcomeId>5460aa92294505.88251413</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary Care teams meeting Cambridgeshire</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DA5F20C6-6209-4EFF-97DD-341095AAAB14</gtr:id><gtr:impact>2 hour seminar describing the work and teaching participants about communication in use of medication

N/A</gtr:impact><gtr:outcomeId>96102B9811D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>School for Primary Care Research</gtr:department><gtr:description>NIHR School of Primary Care Research (2007)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>48F0EDB9-B1B0-4F32-95AB-634B9A5EE188</gtr:id><gtr:outcomeId>80E19E80B410</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4A232DAF-D088-40F1-AD5A-78F9B8389DBC</gtr:id><gtr:title>Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3db333fb521c8c3c45a690799005b0c"><gtr:id>b3db333fb521c8c3c45a690799005b0c</gtr:id><gtr:otherNames>Marteau TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13074_24_22509402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF89A85D-1283-4D07-927F-C93249AA10C5</gtr:id><gtr:title>Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication.</gtr:title><gtr:parentPublicationTitle>BMC family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9b0efb74e3135074737d95d919fe145"><gtr:id>d9b0efb74e3135074737d95d919fe145</gtr:id><gtr:otherNames>Farmer AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2296</gtr:issn><gtr:outcomeId>dMiXPDqt2jX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB0A170E-8E5A-489A-84F1-B7FE2C0BB248</gtr:id><gtr:title>Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.</gtr:title><gtr:parentPublicationTitle>Diabetes research and clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad949aba7b33aadc50ca66686e0874c3"><gtr:id>ad949aba7b33aadc50ca66686e0874c3</gtr:id><gtr:otherNames>Nagrebetsky A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-8227</gtr:issn><gtr:outcomeId>pm_13074_24_22261095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F37C48AB-E1D9-4803-AD1F-4866EAC6910C</gtr:id><gtr:title>Implementation of a nurse-led behaviour change intervention to support medication taking in type 2 diabetes: beyond hypothesised active ingredients (SAMS Consultation Study).</gtr:title><gtr:parentPublicationTitle>Implementation science : IS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bfe535fa67706e8028f8742810c9982"><gtr:id>9bfe535fa67706e8028f8742810c9982</gtr:id><gtr:otherNames>Hardeman W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1748-5908</gtr:issn><gtr:outcomeId>545d096913dff0.15682910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27D5E215-0DB8-45F6-A7A8-EF5B81491399</gtr:id><gtr:title>Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care.</gtr:title><gtr:parentPublicationTitle>Primary care diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fbdb831bfb482909ab2d97c5de1fe1"><gtr:id>b9fbdb831bfb482909ab2d97c5de1fe1</gtr:id><gtr:otherNames>White AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1878-0210</gtr:issn><gtr:outcomeId>hVcLJoQRaK7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACE3CE6E-812C-40E4-B237-39DF0113E1E1</gtr:id><gtr:title>Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3db333fb521c8c3c45a690799005b0c"><gtr:id>b3db333fb521c8c3c45a690799005b0c</gtr:id><gtr:otherNames>Marteau TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>pm_13074_24_21062464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B185A913-1A44-48CC-9529-199AB5427F80</gtr:id><gtr:title>Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity.</gtr:title><gtr:parentPublicationTitle>Annals of behavioral medicine : a publication of the Society of Behavioral Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22b74cf643b62498959e499f1f9f7686"><gtr:id>22b74cf643b62498959e499f1f9f7686</gtr:id><gtr:otherNames>Sutton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0883-6612</gtr:issn><gtr:outcomeId>545110713c4ca0.89569045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F6CBB8C-7230-466C-B51A-A5737B538DDA</gtr:id><gtr:title>An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>BMC family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b2eac2fb9616749f5baa65271de9fd"><gtr:id>59b2eac2fb9616749f5baa65271de9fd</gtr:id><gtr:otherNames>Farmer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2296</gtr:issn><gtr:outcomeId>pm_13074_24_22480341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76EAAEB3-342C-4C2E-A7F8-4899A29E3E9A</gtr:id><gtr:title>Trials to improve blood pressure through adherence to antihypertensives in stroke/TIA: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44dbdadfd2b84599851f61fce39f67c8"><gtr:id>44dbdadfd2b84599851f61fce39f67c8</gtr:id><gtr:otherNames>De Simoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn><gtr:outcomeId>pm_13074_24_23963756</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500267</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>712BA5B2-EB41-48F7-A933-F9EFA1D3314B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>7.1  Individual care needs</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>